Ozempic Patent Expiry Set to Spark Cheaper Weight-Loss Drug Boom in India
The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in…
The patent for semaglutide the key ingredient in Ozempic and Wegovy developed by Novo Nordisk is set to expire in…
Lupin Limited has announced the launch of Dasatinib tablets in the United States after receiving approval from the US Food…
Global pharmaceutical company Lupin Limited announced that it has received the Establishment Inspection Report (EIR) from the U.S. Food and…
India’s pharmaceutical sector is staring at heightened uncertainty following US President Donald Trump’s recent increased tariff on Indian goods. On…
Overweight and obesity are becoming more and more common in India, affecting not only adults but also youngsters. The regional…
Global pharmaceutical giant Lupin Limited (Lupin) said today that it received the United States Food and Drug Administration’s (U.S. FDA)…
Global pharmaceutical company Lupin has announced the acquisition of the Huminsulin brand in India from Eli Lilly and Company. This…
Credit:- Sugandh Khandelwal India’s healthcare and pharmaceutical sectors raised ₹14,811 crore through initial public offerings (IPOs), marking the highest annual…
Lupin Limited a major global pharmaceutical announced on November 18th that it has received approval from the United States Food…
Scope Ophthalmics and Lupin Partner to Launch Eyecare Products in Mexico Scope Ophthalmics, a leader in ophthalmic products, has announced…